Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProPBM: Modified Patient Blood Management Protocol
NCT03888768Unknown
- Sponsor
- Ministry of Health Malaysia
- Start
- Aug 2019
- Primary completion
- Oct 2021
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Ministry of Health Malaysia. Primary endpoint: Incidence of perioperative allogenic blood transfusion up to 6 months. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03888768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03888768.